Created at 8:02 p.m. Jan, 24, 2025
Author: 18k001
Related Note: 1509298828436 4
Rationale for change

THe mutation is listed in the drug name. Not just the V, but also the E.
Source: Other - VEmurafenib for V600E BRAF Inhibition.

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Dermatology::04_Malignant_Skin_Disorders::02_Melanoma #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::22_Dabrafenib/Vemurafenib #AK_Step1_v12::#AMBOSS::Dy01hi #AK_Step1_v12::#OME_banner #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::19_Anticancer_small_molecule_inhibitors::*Dabrafenib_Vemurafenib::Vemurafenib #AK_Step1_v12::#B&B::08_Derm::01_General::10_Skin_Cancer #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::01_Kinase_Inhibitors #AK_Step1_v12::#SketchyPath::12_MSK_&_Derm::04_Derm::02_Malignant_Melanoma